Rosetta Genomics Ltd. — Form D
Rosetta Genomics Ltd. of REHOVOT, L3, a company, filed a Form D exempt-offering notice with the SEC on 2011-03-03. The offering totals $2.7M, of which $2.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-03-03
- Form: D
- Accession: 0001362959-11-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $2.7M
- Amount sold: $2.7M
- Investors: 13
- Date of first sale: 2011-02-23
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-156186
Issuer
- Name: Rosetta Genomics Ltd.
- CIK: 0001362959
- Entity type: Corporation
- Jurisdiction: ISRAEL
- Address: 10 PLAUT STREET, SCIENCE PARK, REHOVOT, L3, 76706
- Phone: 972-73-222-0700
Officers, directors & promoters (24)
| Name | Role | Location |
|---|
| David Sidransky | Director | Germantown, MD |
| BRIAN MARKISON | Director | ROCKVILLE, MD |
| Oded Biran | Executive Officer | Southborough, MA |
| Kenneth Berlin | Director | Monmouth Junction, NJ |
| Kenneth Berlin | Executive Officer | Monmouth Junction, NJ |
| Tali Yaron-Eldar | Director | Tel Aviv, L3 |
| Ranit Aharonov | Executive Officer | Rehovot, L3 |
| Joshua Rosensweig | Director | Rehovot, L3 |
| Tomer Assis | Executive Officer | Rehovot, L3 |
| Gerald Dogon | Director | Rehovot, L3 |
| Isaac Shoshani Bentwich | Director | Rehovot, L3 |
| Joshua Shoshani Rosensweig | Director | Rehovot, L3 |
| Tzipora Shoshani Kupitz | Executive Officer | Rehovot, L3 |
| Gerald Shoshani Dogon | Director | Rehovot, L3 |
| Tami Fishman Jutkowitz | Executive Officer | Rehovot, L3 |
| Brian A Markison | Director | Rehovot, L3 |
| David Shoshani Sidransky | Director | Rehovot, L3 |
| Tali Shoshani Yaron-Eldar | Director | Rehovot, L3 |
| Keren Givli | Executive Officer | Rehovot, L3 |
| Ayelet Chajut | Executive Officer | Rehovot, L3 |
| Racheli Shoshani Vizman | Executive Officer | Rehovot, L3 |
| Yoav Shoshani Chelouche | Director | Rehovot, L3 |
| Moshe Shoshani Many | Director | Rehovot, L3 |
| Tina Fishman Edmonston | Executive Officer | Rehovot, L3 |
Other filings by this issuer (5)
More